Rici Healthcare Holdings Ltd. AI Stock Analysis
Want to see HK:1526 full AI Analyst Report?
Rici Healthcare Holdings Ltd. (1526) AI Stock Analysis
Rici Healthcare Holdings Ltd.
(HKEX:1526)
The stock’s score is driven primarily by a solid but not flawless financial profile, with sustained revenue growth, improved profitability, strong cash generation, and significant deleveraging offset by revenue volatility, moderating ROE, and remaining leverage. A very low P/E ratio and modest dividend yield support an attractive valuation, while neutral to mildly constructive technicals and low volatility provide some confirmation but do not yet signal strong momentum.
Rici Healthcare Holdings Ltd. (1526) vs. iShares MSCI Hong Kong ETF (EWH)
- Market Cap
- HKD 1.42B
- Dividend Yield
- 2.13%
- Average Volume (3M)
- 137.51K
- Price to Earnings (P/E)
- 4.2
- Beta (1Y)
- 0.12
- Revenue Growth
- 1.25%
- EPS Growth
- 12.60%
- Country
- Hong Kong
- Employees
- 8,542
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Care Facilities
Rici Healthcare Holdings Ltd. Business Overview & Revenue Model
Company Description
Rici Healthcare Holdings Limited operates as an investment holding company, managing a variety of healthcare establishments across the People's Republic of China. Its operations encompass general and specialized hospitals, clinics, and medical examin...
How the Company Makes Money
null
Rici Healthcare Holdings Ltd. Financial Statement Overview
Summary
Revenue has grown from roughly RMB1.9 billion to around RMB2.8–3.0 billion with generally double‑digit growth, margins have improved to over 40% gross and 10–12% net, operating and free cash flow are consistently strong and rising, and leverage has fallen sharply, but revenue growth is somewhat volatile, ROE has moderated from above 30% to below 20%, and debt, while reduced, remains meaningful.
Income Statement
82Very PositiveBalance Sheet
74PositiveCash Flow
85Very Positive| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.79B | 2.80B | 2.92B | 2.99B | 2.38B | 2.38B |
| Gross Profit | 1.20B | 1.21B | 1.17B | 1.25B | 927.20M | 975.22M |
| EBITDA | 1.03B | 1.10B | 1.05B | 1.07B | 814.35M | 905.21M |
| Net Income | 296.78M | 307.13M | 297.32M | 363.80M | 290.79M | 181.55M |
Balance Sheet | ||||||
| Total Assets | 4.69B | 4.88B | 4.86B | 4.64B | 4.57B | 4.54B |
| Cash, Cash Equivalents and Short-Term Investments | 1.10B | 1.18B | 1.12B | 811.21M | 720.14M | 784.36M |
| Total Debt | 1.90B | 2.01B | 2.30B | 2.27B | 2.30B | 2.74B |
| Total Liabilities | 2.99B | 3.16B | 3.48B | 3.52B | 3.66B | 3.95B |
| Stockholders Equity | 1.68B | 1.65B | 1.35B | 1.13B | 953.92M | 677.50M |
Cash Flow | ||||||
| Free Cash Flow | 541.76M | 561.55M | 584.35M | 487.07M | 396.33M | 356.41M |
| Operating Cash Flow | 707.45M | 719.39M | 790.58M | 826.29M | 706.37M | 681.07M |
| Investing Cash Flow | -199.93M | -301.48M | -140.02M | -147.00M | -273.99M | -269.13M |
| Financing Cash Flow | -454.75M | -388.92M | -351.23M | -592.72M | -495.23M | -193.99M |
Rici Healthcare Holdings Ltd. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1526, the sentiment is Positive. The current price of 0.94 is above the 20-day moving average (MA) of 0.93, above the 50-day MA of 0.89, and above the 200-day MA of 0.89, indicating a bullish trend. The MACD of 0.02 indicates Negative momentum. The RSI at 52.91 is Neutral, neither overbought nor oversold. The STOCH value of 74.75 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:1526.
Rici Healthcare Holdings Ltd. Peers Comparison
Overall Rating
- HK:152679.2Outperform
HK:330976Outperform
HK:221973Outperform
HK:184652Neutral
HK:990651Neutral
HK:388642Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| HK:1526 | 79Outperform | HKD 1.59B | 4.24 | 17.86% | 2.13% | 1.25% | 12.60% |
| HK:3309 | 76Outperform | HKD 1.20B | 12.05 | 5.57% | 2.06% | 4.75% | ― |
| HK:2219 | 73Outperform | HKD 1.69B | 8.47 | 6.97% | 10.14% | 3.85% | -1.23% |
| HK:1846 | 52Neutral | HKD 665.13M | 272.73 | 0.20% | 2.10% | 20.54% | -96.74% |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| HK:9906 | 51Neutral | HKD 936.00M | 23.38 | 5.59% | ― | ― | ― |
| HK:3886 | 42Neutral | HKD 1.11B | 83.33 | 0.48% | 1.03% | -3.26% | ― |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| HK:1526 | Rici Healthcare Holdings Ltd. | 0.94 | -0.02 | -1.88% | |
| HK:9906 | Honliv Healthcare Management Group Co Ltd | 1.56 | -0.05 | -3.11% | |
| HK:1846 | EuroEyes International Eye Clinic Limited | 2.10 | -1.14 | -35.25% | |
| HK:2219 | Chaoju Eye Care Holdings Ltd. | 2.39 | 0.10 | 4.14% | |
| HK:3309 | C-MER Eye Care Holdings Limited | 1.01 | -0.73 | -41.83% | |
| HK:3886 | Town Health International Medical Group Ltd. | 0.17 | -0.09 | -33.21% |
Rici Healthcare Holdings Ltd. Corporate Events
Rici Healthcare Taps Xunfei AI in New Health-Tech Alliance
Rici Healthcare Holdings’ subsidiary Shanghai Rich Medical Investment Group has signed a cooperation framework agreement with Xunfei Healthcare Technology, a listed leader in China’s AI healthcare sector, to integrate artificial intelligence into Ric...
Rici Healthcare Shareholders Approve Auditor Resignation at Extraordinary Meeting
Rici Healthcare Holdings Limited announced that shareholders approved all resolutions put forward at its extraordinary general meeting held in Shanghai on October 12, 2026. The meeting was conducted by poll voting, underscoring the company’s adherenc...
Rici Healthcare Calls EGM to Approve Change of Auditor
Rici Healthcare Holdings Ltd., a Cayman Islands–incorporated healthcare services provider listed in Hong Kong, operates medical and health-related businesses across mainland China with corporate management in Shanghai. Its board comprises executive a...
Rici Healthcare Moves to Replace Auditor BDO With Rongcheng After Fee Review
Rici Healthcare Holdings Ltd. has announced a proposed change of auditor, with BDO resigning as the company’s auditor following the passing of a relevant resolution at an extraordinary general meeting. Subject to shareholder approval, the board, acti...
Rici Healthcare Posts Softer Interim Results and Halts Interim Dividend
Rici Healthcare Holdings Ltd., a Cayman Islands–incorporated healthcare group listed in Hong Kong, operates through subsidiaries to deliver medical and healthcare services across mainland China, positioning itself within the growing Chinese healthcar...
Rici Healthcare Sets Board Meeting to Review Interim Results and Dividend
Rici Healthcare Holdings Ltd. has scheduled a board meeting for August 28, 2026, to review and approve the interim results for the six months ended June 30, 2026. The board will also consider the potential declaration of an interim dividend, a decisi...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Aug 21, 2026